JANX — Janux Therapeutics Inc. price, chart and key statistics

Price data

Price

$17.20

YTD price return

+24.64%

YTD total return

+24.64%

Next earnings

Nov 5, 2026

Market cap

1.1B2021-06 1B2026-10 1.1B+1.3% over the window

Enterprise value

101.6M

Shares outstanding

61.1M2020-12 1M2026-06 61.1M+5741.5% over the window

52W low

$12.12

52W high

$35.34

From 52W high

-51.33%

From 52W low

+41.91%

52W range

22%

Volume

Rel volume

0.95×

30D volume

905.8K

30D $ vol

15.5M

Fundamentals

Sales (ttm)

24M2020-12 02026-06 24M

Sales/share

$0.392020-12 $0.002026-06 $0.39

EPS (ttm)

-$1.642021-12 -$1.392026-06 -$1.64+18.2% over the window

FCF (ttm)

-41.9M2020-12 -4.4M2026-06 -41.9M+859.6% over the window

FCF/share

-$0.692020-12 -$4.172026-06 -$0.69-83.6% over the window

Book value/share

$15.182020-12 -$13.992026-06 $15.18-208.5% over the window

Net margin

-427.47%2021-12 -898.3%2026-06 -427.5%-52.4% over the window

ROE

-11.06%2021-12 -8.9%2026-06 -11.1%+24.0% over the window

ROA

-10.18%2020-12 -41.8%2026-06 -10.2%-75.7% over the window

Current ratio

16.352020-12 5.052026-06 16.35+223.8% over the window

Growth (CAGR, ttm) · 10Y

Sales

+5381.97%2025-06-30 → 2026-06-30439K → 24M (+5367.0% total)+45.67%2023-06-30 → 2026-06-307.8M → 24M (+209.2% total)n/an/a

Shares

+1.74%2025-06-30 → 2026-06-3060.1M → 61.1M (+1.7% total)+9.83%2023-06-30 → 2026-06-3046.1M → 61.1M (+32.5% total)+8.00%2021-06-30 → 2026-06-3041.6M → 61.1M (+46.9% total)n/a

Per-share growth (CAGR, ttm) · 10Y

Sales/share

+5288.40%2025-06-30 → 2026-06-30$0.01 → $0.39 (+5273.7% total)+32.62%2023-06-30 → 2026-06-30$0.17 → $0.39 (+133.3% total)n/an/a

Book value/share

-7.92%2025-06-30 → 2026-06-30$16.48 → $15.18 (-7.9% total)+32.73%2023-06-30 → 2026-06-30$6.49 → $15.18 (+133.9% total)+10.42%2021-06-30 → 2026-06-30$9.25 → $15.18 (+64.1% total)n/a

Price

-36.10%2025-10-20 → 2026-10-20$26.91 → $17.20 (-36.1% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+36.58%2023-10-20 → 2026-10-20$6.75 → $17.20 (+154.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-5.10%2021-10-20 → 2026-10-20$22.34 → $17.20 (-23.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/a

Total return

-36.10%2025-10-20 → 2026-10-20$26.91 → $17.20 (-36.1% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+36.58%2023-10-20 → 2026-10-20$6.75 → $17.20 (+154.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-5.10%2021-10-20 → 2026-10-20$22.34 → $17.20 (-23.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

-10.5×2021-06 -153.042026-10 -10.25-93.3% over the window

Fwd P/E

-6.5×

P/S (ttm)Market cap ÷ TTM revenue.

43.8×2021-12 225.802026-10 43.81-80.6% over the window

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

1.1×2021-06 2.702026-10 1.13-58.0% over the window

EV/Sales (ttm)

4.2×

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

-3.99%2021-12 -2.2%2026-06 -4.5%+98.6% over the window

Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 61.1M ÷ 60.1M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.

-1.74%

Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-1.74%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($1.4B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.

-1.74%

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($1.1B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

0.00%2021-12 0.0%2026-06 0.0%

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $0) ÷ today's market cap ($1.1B). Same caveat as the cash buyback yield.

0.00%2021-12 0.0%2026-06 0.0%

Vs own 10Y history

P/S

6th

P/B

17th